Pharmacokinetic and Tolerability Study of NFC-1 in Subjects Aged 6-17 Years With ADHD

Clinical trial NCT03006367 · COMPLETED

Trial details

NCT number

NCT03006367

Sponsor

Aevi Genomic Medicine, LLC, a Cerecor company

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2017-01-07

Primary completion

2017-02-26

Enrollment

32

View on ClinicalTrials.gov